Breast Cancer Sessions: Treatment de-escalation in TNBC
The development of complex and effective therapies has improved outcomes in breast cancer, highlighting the need for strategies to escalate…
Date: 20th May 2022
Trial updates from ESMO Breast Cancer 2022: TUXEDO-1, monarchE, KEYNOTE-355
The European Society for Clinical Oncology (ESMO) Breast Cancer Conference was a hybrid event, held virtually and Berlin, Germany. This…
Date: 16th May 2022
Breast Cancer Sessions: Treatment de-escalation in TNBC
The development of complex and effective therapies has improved outcomes in breast cancer, highlighting the need for strategies to escalate…
Date: 20th May 2022
Trial updates from ESMO Breast Cancer 2022: TUXEDO-1, monarchE, KEYNOTE-355
The European Society for Clinical Oncology (ESMO) Breast Cancer Conference was a hybrid event, held virtually and Berlin, Germany. This…
Date: 16th May 2022
Updates in GI cancers from AACR 2022
This year’s American Association for Cancer Research (AACR) congress took place in New Orleans, LA, from 8-13 April 2022, and…
Date: 6th May 2022
Expanding use of artificial intelligence (AI) in oncology
Improvements in early detection, diagnosis, and management have decreased cancer-related mortality, however, challenges associated with personalized care remain. Artificial intelligence…
Date: 29th April 2022
The evolving role of nurses amidst global pandemic: perspectives, and highlights from cancer nursing leaders
In a world that is still acclimatizing to the COVID-19 pandemic, the fragility of many aspects of our society has…
Date: 22nd April 2022
The GU Cancer Sessions: Prostate & kidney cancer at ASCO GU 2022
In this podcast, we hear from genitourinary (GU) cancer experts Tian Zhang, MD, Duke Cancer Center, Durham, NC, and Scott…
Date: 11th April 2022
Lung Cancer Screening: Current state and future directions
Lung cancer is one of the most common cancers in the world, and has a very low survival rate, partly…
Date: 1st April 2022
Novel treatment approaches in HR+/HER2- breast cancer
Resistance to endocrine therapy in patients with hormone-receptor positive (HR+), HER2-negative breast cancer inevitably results in relapse and metastasis, leading…
Date: 25th March 2022
New treatment approaches for advanced or metastatic urothelial carcinoma
Clinical trials presented at the the American Society of Clinical Oncology (ASCO) Genitourinary Cancers (GU) Symposium 2022 have been investigating…
Date: 18th March 2022
The Breast Cancer Sessions: Highlights from SABCS 2021
The San Antonio Breast Cancer Symposium (SABCS) 2021 saw ground-breaking data and developments in breast cancer being presented and in…
Date: 11th March 2022
The GI Cancer Sessions: Highlights from ASCO GI 2022
In this episode of the VJOncology podcast, a panel of leading gastrointestinal (GI) cancer experts offer their perspectives on the…
Date: 4th March 2022
Prostate Cancer Highlights from ASCO GU 2022
The ASCO Genitourinary (GU) Cancers Symposium took place on the 17-19th February 2022, in San Francisco, CA. Leading experts gave…
Date: 25th February 2022
Updates on HER2-positive breast cancer
HER2-positive breast cancer accounts for 15-20% of all breast cancer cases. It was associated with a poor prognosis until the…
Date: 15th February 2022
BTOG 2022: Highlights in lung cancer
For patients with lung cancer, surgical resection is a treatment option and perioperative management is imperative to improve surgical outcomes….
Date: 11th February 2022
The multidisciplinary use of ctDNA in gastrointestinal cancers
Gastrointestinal (GI) cancer remains one of the leading cause of global cancer mortality. The current standard for diagnosing GI cancers…
Date: 2nd February 2022
SITC 2021: Updates on the use of cellular therapies in solid tumors
Cellular immunotherapy approaches have proven to be highly effective in the treatment of patients with hematological malignancies over recent years….
Date: 19th January 2022
Breast Cancer Sessions: Highlights from SABCS 2021 with Lisa Carey & Aleix Prat
The San Antonio Breast Cancer Symposium 2021 featured exciting developments in early and advanced breast cancer, basic science, and translational…
Date: 14th January 2022
Immunotherapy updates from SABCS 2021 with Heather McArthur & Kevin Kalinsky
The success of immunotherapy in the treatment of solid tumors has created hope for its potential in breast cancer. The…
Date: 4th January 2022
The Lung Cancer Sessions: Advances in EGFR-mutated NSCLC
The Lung Cancer Sessions from VJOncology aim to provide interesting perspectives from leading experts on the big topics in lung…
Date: 25th November 2021
ISLB 2021: Current standards and future directions for liquid biopsy
Liquid biopsy is an exciting field, with many promising advances in recent years. In this podcast, we cover a range…
Date: 12th November 2021
Prostate Cancer Highlights from ESMO 2021 with Robert Jones
The European Society for Medical Oncology (ESMO) 2021 Congress saw many exciting clinical trials presented from across the field of…
Date: 28th October 2021
The GU Cancer Sessions: Bladder Highlights from ESMO 2021
VJOncology has assembled a group of leading genitourinary cancer experts to examine and discuss the latest developments in bladder cancer…
Date: 19th October 2021
The Skin Cancer Sessions: Highlights from ASCO 2021
VJOncology has assembled a panel of world-renowned skin cancer experts to examine and discuss the exciting advances in skin cancer…
Date: 7th October 2021
The Lung Cancer Sessions: Highlights from ASCO 2021
Following the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, VJOncology brought together a group of leading lung cancer…
Date: 7th October 2021
The GI Cancer Sessions: Highlights from ASCO 2021
At the virtual 2021 American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, important advances and potentially practice-changing trial data…
Date: 7th October 2021
Key clinical trial data in urothelial carcinoma at ASCO 2021
Chemotherapy is central to the treatment of advanced or metastatic urothelial carcinoma (UC), and platinum-based treatments, like cisplatin, have been…
Date: 10th September 2021
Prostate Cancer Highlights from ASCO 2021 with Pedro Barata
This year, at the American Society of Clinical Oncology (ASCO) Virtual Meeting 2021, experts came together virtually to present and…
Date: 23rd August 2021
The Breast Cancer Sessions: Highlights from ASCO 2021
VJOncology has assembled an international panel of leading breast cancer experts to discuss the latest advances and data from the…
Date: 18th August 2021
The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO 2021
During the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting, an exciting array of advances in genitourinary (GU) cancer…
Date: 18th August 2021
ASCO 2021: Immunotherapy updates in lung cancer
Various immunotherapies including checkpoint inhibitors have emerged as effective treatment options for patients with non-small cell lung cancer (NSCLC). Immune…
Date: 4th August 2021
EAU 2021: updates in testicular cancer
Whilst advances in diagnostic procedures, radiotherapies, cisplatin-based chemotherapy, and surgery have meant that testicular cancer is curable in around 95%…
Date: 28th July 2021
Highlights from ESMO WCGIC 2021: VALENTINO, KEYNOTE-811 & BEACON-CRC
The ESMO World Congress on Gastrointestinal Cancer (WCGIC) 2021 annual meeting took place virtually this year and leading experts came…
Date: 15th July 2021
What’s new? Treating breast cancer with brain metastases
Metastatic breast cancer is breast cancer that has spread to other regions of the body, most commonly the liver, brain,…
Date: 13th July 2021
Global breast cancer care
Healthcare systems around the world differ in financial and political situations. Therefore, it is vital to implement a global outlook…
Date: 13th July 2021
Latest developments in immunotherapy for patients with melanoma
Surgery is an effective treatment for non-metastatic melanoma, however, advanced melanoma demands additional intervention, such as chemotherapy or immunotherapy. The…
Date: 1st July 2021
ASCO 2021: PSMA-targeted radionuclide therapy for prostate cancer
Prostate-specific membrane antigen (PSMA) is overexpressed in more than 80% of prostate cancer tumors, making it a promising diagnostic and…
Date: 25th June 2021
The Lung Cancer Sessions: Highlights from BTOG 2021
VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest developments in lung cancer presented…
Date: 22nd June 2021
ESMO Breast 2021: updates on immunotherapy
Breast cancer is the most common type of cancer in women. Although most cases of early-stage non-metastatic disease are curable…
Date: 10th June 2021
The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO GU 2021
VJOncology has assembled a panel of leading experts, who offer their perspectives on the latest bladder and kidney cancer data…
Date: 14th May 2021
Sequencing HER2-targeting therapies in the metastatic breast cancer space
Treatment approaches in breast cancer are multimodal, and with the onset of novel immunotherapies and targeted agents, the therapeutic landscape…
Date: 14th May 2021
Latest news in GU: CAR-T in RCC, updates from IMvigor130, & liquid biopsies in prostate cancer
The American Association for Cancer Research Annual Meeting 2021 (AACR) took place virtually this year and showcased an array across…
Date: 13th May 2021
The GU Sessions: Prostate Cancer Highlights from ASCO GU 2021
The 2021 American Society of Clinical Oncology (ASCO) Genitourinary Cancer Symposium showcased a range of exciting clinical trial data and…
Date: 13th May 2021
BTOG 2021: KRAS targeting and oncogenically-driven lung cancer
Traditional treatments for lung cancer include chemotherapy, radiotherapy and surgery, however the identification of oncogenic drivers, such as EGFR, ALK…
Date: 12th May 2021
The Breast Cancer Sessions: a focus on the St. Gallen Consensus
At the 17th St. Gallen International Breast Cancer Conference 2021, leading experts gathered virtually to take part in the renowned…
Date: 26th April 2021
Predictive and prognostic biomarkers in breast cancer
Following a breast cancer diagnosis, the most immediate challenges in patient management are the determination of prognosis and identification of…
Date: 7th April 2021
The Lung Cancer Sessions: highlights from IASLC WCLC
VJOncology has assembled an international panel of leading experts in lung cancer and mesothelioma to bring you the key highlights…
Date: 18th February 2021
The GI Cancer Sessions: Highlights from ASCO GI 2021
The virtual American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium 2021 brought together leading experts in GI cancer who…
Date: 12th February 2021
The Breast Cancer Sessions: Highlights from SABCS 2020
The virtual San Antonio Breast Cancer Symposium (SABCS) 2020 brought together leading experts in breast cancer who updated the community…
Date: 25th January 2021
SABCS 2020 highlights: immunotherapy, novel agents & trial updates
In December, the San Antonio Breast Cancer Symposium (SABCS) 2020 convened virtually and featured key updates in the treatment and…
Date: 8th January 2021
Key trial updates at SABCS 2020: monarchE, RxPONDER & ASCENT
The San Antonio Breast Cancer Symposium (SABCS) 2020 annual meeting took place virtually this year and showcased recent advances in…
Date: 15th December 2020
Updates in non-small cell lung cancer from ESMO
Significant advances have been made in the treatment of non-small cell lung cancer (NSCLC), the most common form of lung…
Date: 3rd November 2020
Highlights from EADO 2020: novel therapies, neoadjuvant approaches & COVID-19
The 16th European Association of Dermato-Oncology (EADO) meeting took place virtually this year and provided an opportunity to hear from…
Date: 29th October 2020
The Lung Cancer Sessions: learnings from the ESMO 2020 Science Weekend
The European Society for Medical Oncology (ESMO) 2020 Virtual Congress brought together leading experts in oncology who updated the community…
Date: 14th October 2020
The ONS/EONS Congress Roundtable Discussion with VJOncology and OncoAlert
The treatment of cancer continues to evolve rapidly, with expanded therapeutic options and changes to clinical practice. Additionally, the care…
Date: 10th September 2020
Prioritizing patients for breast cancer surgery during COVID-19
Patients with cancer consistently demonstrate poorer post-COVID-19 infection outcomes, and as a result of the pandemic, cancer services within the…
Date: 3rd August 2020
Genotyping in lung cancer and multi-cancer detection
Using precision genotyping for identifying resistance mechanisms in advanced lung cancer can help guide treatment decisions and prolong the benefit…
Date: 1st July 2020
Molecular testing for lung cancer in the UK
Molecular testing for lung cancer mutations plays an important role in the care of patients, by enabling quicker access to…
Date: 13th May 2020
Living with and beyond cancer: a patient’s quality of life is just as important as survival
The views of patients with cancer, and their survivorship, is becoming increasingly important to cancer research. This podcast not only…
Date: 4th February 2019
Advancing immunotherapy for solid tumors
Immunotherapy has the potential to treat all types of cancer, making it a highly lucrative area of research. Since the…
Date: 23rd November 2018
Updates in breast cancer: recent clinical trials, immunotherapy, challenges & future treatment outlook
This is an exciting time in the breast cancer field, with advances in the development of treatments and knowledge regarding…
Date: 11th October 2018
Hot topics in oncology: precision medicine, biomarkers & immunotherapy
In preparation for the ESMO 2018 congress, we’ve put together a series of hot topics in oncology summing up themes…
Date: 14th September 2018
Bladder cancer: advances in the spotlight and what these mean for therapy
Over the past few years, the field of bladder cancer has seen an array of exciting clinical advancements, ranging from…
Date: 16th August 2018
